ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Dec 2025
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
December 2025
Nuclear Technology
Fusion Science and Technology
November 2025
Latest News
Deep Fission to break ground this week
With about seven months left in the race to bring DOE-authorized test reactors on line by July 4, 2026, via the Reactor Pilot Program, Deep Fission has announced that it will break ground on its associated project on December 9 in Parsons, Kansas. It’s one of many companies in the program that has made significant headway in recent months.
J. Coulot, F. Lavielle, A. Faggiano, N. Bellon, B. Aubert, M. Schlumberger, M. Ricard
Nuclear Science and Engineering | Volume 149 | Number 2 | February 2005 | Pages 124-130
Technical Paper | doi.org/10.13182/NSE05-A2483
Articles are hosted by Taylor and Francis Online.
Standard macroscopic methods used to assess the dose in nuclear medicine are limited to cases of homogeneous radionuclide distributions and provide dose estimations at the organ level. In a few applications, like radioimmunotherapy, the mean dose to an organ is not suitable to explain clinical observations, and knowledge of the dose at the tissular level is mandatory. Therefore, one must determine how particles lose their energy and what is the best way to represent tissues. The Monte Carlo method is appropriate to solve the problem of particle transport, but the question of the geometric representation of biology remains. In this paper, we describe a software (CLUSTER3D) that is able to build randomly biologically representative sphere cluster geometries using a statistical description of tissues. These geometries are then used by our Monte Carlo code called DOSE3D to perform particle transport. First results obtained on thyroid models highlight the need of cellular and tissular data to take into account actual radionuclide distributions in tissues. The flexibility and reliability of the method makes it a useful tool to study the energy deposition at various cellular and tissular levels in any configuration.